Related Experiment Video
Updated: Mar 17, 2026
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Gene Therapy for Lung Cancer
Humberto Lara-Guerra1, Jack A Roth1
1Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Abstract:
Gene therapy was originally conceived to treat monogenic diseases. The replacement of a defective gene with a functional gene can theoretically cure the disease. In cancer, multiple genetic defects are present and the molecular profile changes during the course of the disease, making the replacement of all defective genes impossible. To overcome these difficulties, various gene therapy strategies have been adopted, including immune stimulation, transfer of suicide genes, inhibition of driver oncogenes, replacement of tumor-suppressor genes that could mediate apoptosis or anti-angiogenesis, and transfer of genes that enhance conventional treatments such as radiotherapy and chemotherapy. Some of these strategies have been tested successfully in non-small-cell lung cancer patients and the results of laboratory studies and clinical trials are reviewed herein.
Insights
Gene therapy offers innovative cancer treatments beyond single-gene disorders. Novel strategies like immune stimulation and suicide gene transfer show promise in clinical trials for non-small-cell lung cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Gene therapy was initially developed for monogenic diseases by replacing defective genes.
- Cancer involves numerous genetic defects and dynamic molecular changes, complicating traditional gene replacement approaches.
Purpose of the Study:
- To review diverse gene therapy strategies adapted for cancer treatment.
- To summarize successful applications and ongoing research in non-small-cell lung cancer.
Main Methods:
- Review of laboratory studies and clinical trials on gene therapy for cancer.
- Exploration of strategies including immune stimulation, suicide gene transfer, oncogene inhibition, tumor-suppressor gene replacement, and enhancement of conventional therapies.
Main Results:
- Various gene therapy strategies have been developed to address the complexity of cancer genetics.
- Successful testing of some strategies in non-small-cell lung cancer patients has been documented.
Conclusions:
- Gene therapy has evolved beyond monogenic diseases to address complex cancers.
- Emerging gene therapy approaches hold significant potential for improving non-small-cell lung cancer treatment outcomes.
Related Concept Videos
00:59Gene Therapy
00:59Gene Therapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...